Jerikias Marumure
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jerikias Marumure has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Zakio Makuvara
School of Natural Sciences, Great Zimbabwe University, Private Bag 1235, Masvingo, Zimbabwe
6 shared publications - Claudious Gufe
Biological Sciences Department Bindura University of Science Education Bindura Zimbabwe
3 shared publications Claudious Gufe
Central Veterinary Laboratories
2 shared publications- Marvelous Goredema
Biological Sciences Department, Bindura University of Science Education, 741 Chimurenga Road, Off Trojan Road, Bindura, Zimbabwe
2 shared publications - Monde Alfred Nyila
Department of Life and Consumer Sciences, College of Agriculture and Environmental Sciences, University of South Africa
2 shared publications - Rangarirayi Karidzagundi
Materials Development Unit, Zimbabwe Open University, P.O. Box MP1119, Mount Pleasant, Harare, Zimbabwe
2 shared publications
Latest Publications
- Open Access
- 14 August 2025
- Published by SAGE Publications in Natural Product Communications
- Vol. 20 (8)
Chemical Profiling of Kirkia acuminata Oliv. Stembark Extracts by GC-MS Analysis and Evaluation of its Antibacterial and Cytotoxic Activity
Background: Kirkia acuminata is a medicinal plant highly renowned in traditional African medicine for its ability to treat various diseases. Objectives: This study aims to evaluate the pharmacological and phytochemical properties of Kirkia acuminata . Methods: The Gas Chromatography-Mass Spectrometry (GC-MS) technique was employed to investigate the phytochemical composition, while the antibacterial efficacy of the stembark extract of the plant species was assessed against Vibrio cholerae using the agar well diffusion method. The Brine Shrimp Lethality Assay (BSLA) was utilized to evaluate the cytotoxic characteristics of the plant species. Results: The GC-MS analysis identified 27 different phytochemical constituents, with the major compounds being tetrapentacontane (23.04%), tetracontane (13.19%), 1-docosanol (12.89%), 2,4-bis(1,1-dimethylethyl)-phenol (9.49%), octacosanol (7.35%), 1-nonadecene (6.97%), and 1-heptadecene (5.52%). These compounds have previously been described as having antimicrobial activity. The stembark extract exhibited notable antibacterial activity, with a minimum inhibitory concentration (MIC) of ≤ 1 mg/mL. Furthermore, the extract showed no signs of toxicity, as indicated by the Lethal Concentration 50 (LC 50 ) values of 1583.34 μg/mL. Conclusion: These findings offer scientific data that supports the use of the plant species in traditional medicine. However, more research is needed to evaluate any toxicological effects of long-term or repeated plant species concoctions use in traditional medicine. Furthermore, further research is necessary to isolate phytochemical constituents and better understand their mechanisms of action.
- 14 August 2025
- Published by SAGE Publications in Natural Product Communications
- Vol. 20 (8)
Open AccessChemical Profiling of Kirkia acuminata Oliv. Stembark Extracts by GC-MS Analysis and Evaluation of its Antibacterial and Cytotoxic Activity
Background: Kirkia acuminata is a medicinal plant highly renowned in traditional African medicine for its ability to treat various diseases. Objectives: This study aims to evaluate the pharmacological and phytochemical properties of Kirkia acuminata . Methods: The Gas Chromatography-Mass Spectrometry (GC-MS) technique was employed to investigate the phytochemical composition, while the antibacterial efficacy of the stembark extract of the plant species was assessed against Vibrio cholerae using the agar well diffusion method. The Brine Shrimp Lethality Assay (BSLA) was utilized to evaluate the cytotoxic characteristics of the plant species. Results: The GC-MS analysis identified 27 different phytochemical constituents, with the major compounds being tetrapentacontane (23.04%), tetracontane (13.19%), 1-docosanol (12.89%), 2,4-bis(1,1-dimethylethyl)-phenol (9.49%), octacosanol (7.35%), 1-nonadecene (6.97%), and 1-heptadecene (5.52%). These compounds have previously been described as having antimicrobial activity. The stembark extract exhibited notable antibacterial activity, with a minimum inhibitory concentration (MIC) of ≤ 1 mg/mL. Furthermore, the extract showed no signs of toxicity, as indicated by the Lethal Concentration 50 (LC 50 ) values of 1583.34 μg/mL. Conclusion: These findings offer scientific data that supports the use of the plant species in traditional medicine. However, more research is needed to evaluate any toxicological effects of long-term or repeated plant species concoctions use in traditional medicine. Furthermore, further research is necessary to isolate phytochemical constituents and better understand their mechanisms of action.
- Open Access
Global Occurrence of Cyanotoxins in Drinking Water Systems: Recent Advances, Human Health Risks, Mitigation, and Future Directions
This paper applies a semi-quantitative approach to review the diversity, environmental controls, detection methods, human health risks, and mitigation of cyanotoxins in drinking water systems (DWSs). It discusses the environmental factors controlling the occurrence of cyanotoxins, presents the merits and limitations of emerging methods of their detection (qPCR, liquid chromatography–mass spectrometry, and electrochemical biosensors), and outlines the human exposure pathways and health outcomes with identification of high-risk groups and settings. High-risk groups include (1) communities relying on untreated drinking water from unsafe, polluted water sources and (2) low-income countries where cyanotoxins are not routinely monitored in DWSs. The fate and behavior processes are discussed, including removing cyanotoxins in DWSs based on conventional and advanced treatment processes. The available methods for cyanotoxin removal presented in this paper include (1) polymer-based adsorbents, (2) coagulation/flocculation, (3) advanced oxidation processes, (4) ultra- and nanofiltration, and (5) multi-soil layer systems. Future research should address (1) detection and fate in storage and conveyance facilities and at the point of consumption, (2) degradation pathways and toxicity of by-products or metabolites, (3) interactive health effects of cyanotoxins with legacy and emerging contaminants, (4) removal by low-cost treatment techniques (e.g., solar disinfection, boiling, bio-sand filtration, and chlorination), (5) quantitative health risk profiling of high-risk groups, and (6) epidemiological studies to link the prevalence of human health outcomes (e.g., cancer) to cyanotoxins in DWSs.
Open AccessGlobal Occurrence of Cyanotoxins in Drinking Water Systems: Recent Advances, Human Health Risks, Mitigation, and Future Directions
This paper applies a semi-quantitative approach to review the diversity, environmental controls, detection methods, human health risks, and mitigation of cyanotoxins in drinking water systems (DWSs). It discusses the environmental factors controlling the occurrence of cyanotoxins, presents the merits and limitations of emerging methods of their detection (qPCR, liquid chromatography–mass spectrometry, and electrochemical biosensors), and outlines the human exposure pathways and health outcomes with identification of high-risk groups and settings. High-risk groups include (1) communities relying on untreated drinking water from unsafe, polluted water sources and (2) low-income countries where cyanotoxins are not routinely monitored in DWSs. The fate and behavior processes are discussed, including removing cyanotoxins in DWSs based on conventional and advanced treatment processes. The available methods for cyanotoxin removal presented in this paper include (1) polymer-based adsorbents, (2) coagulation/flocculation, (3) advanced oxidation processes, (4) ultra- and nanofiltration, and (5) multi-soil layer systems. Future research should address (1) detection and fate in storage and conveyance facilities and at the point of consumption, (2) degradation pathways and toxicity of by-products or metabolites, (3) interactive health effects of cyanotoxins with legacy and emerging contaminants, (4) removal by low-cost treatment techniques (e.g., solar disinfection, boiling, bio-sand filtration, and chlorination), (5) quantitative health risk profiling of high-risk groups, and (6) epidemiological studies to link the prevalence of human health outcomes (e.g., cancer) to cyanotoxins in DWSs.
- Open Access
- 1 January 2024
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2024 (1) , 1981991
Cholera Outbreaks in Zimbabwe: An In‐Depth Analysis of Drivers, Constraints and Reimagining the Use of Medicinal Plants
Cholera, an intestinal infection caused by Vibrio cholerae, poses a severe threat to public health, particularly in developing countries. This narrative review discusses drivers for cholera outbreaks, challenges and viable alternatives, in Zimbabwe. A literature search was conducted using electronic databases notably ScienceDirect, Google Scholar and PubMed, as well as thesis and conference papers. Evidence indicates that the epidemiology, as well as risk factors, includes (1) extreme droughts; (2) political meddling in health issues and water supply; (3) natural disasters; (4) migration; (5) problems with water and sanitation; and (6) the endemic nature of the causative agent as well as its development of drug resistance. Reliable supply of clean water and proper sanitation and hygiene as the main key to prevention is emphasised. The use of antibiotics and vaccines for therapy, as well as the use of medicinal plants in traditional medicine, is discussed. Kirkia acuminata and Ziziphus mucronata root and stem bark infusions or decoctions were revealed to be the most common folklore treatments for cholera in rural communities. The potential of medicinal plants as anti‐Vibrio cholerae remedies based on their positive antibacterial assays, and mechanism of action is also presented. Finally, the development of innovative anti‐Vibrio cholerae therapeutics based on natural leads and compounds and adapted for use in resource‐constrained cholera‐prone areas is viewed as a potential option, to complement cholera prevention and treatment, particularly in resource‐limited endemic areas.
- 1 January 2024
- Published by Wiley in Journal of Tropical Medicine
- Vol. 2024 (1) , 1981991
Open AccessCholera Outbreaks in Zimbabwe: An In‐Depth Analysis of Drivers, Constraints and Reimagining the Use of Medicinal Plants
Cholera, an intestinal infection caused by Vibrio cholerae, poses a severe threat to public health, particularly in developing countries. This narrative review discusses drivers for cholera outbreaks, challenges and viable alternatives, in Zimbabwe. A literature search was conducted using electronic databases notably ScienceDirect, Google Scholar and PubMed, as well as thesis and conference papers. Evidence indicates that the epidemiology, as well as risk factors, includes (1) extreme droughts; (2) political meddling in health issues and water supply; (3) natural disasters; (4) migration; (5) problems with water and sanitation; and (6) the endemic nature of the causative agent as well as its development of drug resistance. Reliable supply of clean water and proper sanitation and hygiene as the main key to prevention is emphasised. The use of antibiotics and vaccines for therapy, as well as the use of medicinal plants in traditional medicine, is discussed. Kirkia acuminata and Ziziphus mucronata root and stem bark infusions or decoctions were revealed to be the most common folklore treatments for cholera in rural communities. The potential of medicinal plants as anti‐Vibrio cholerae remedies based on their positive antibacterial assays, and mechanism of action is also presented. Finally, the development of innovative anti‐Vibrio cholerae therapeutics based on natural leads and compounds and adapted for use in resource‐constrained cholera‐prone areas is viewed as a potential option, to complement cholera prevention and treatment, particularly in resource‐limited endemic areas.
- Open Access
- 16 June 2023
- Published by MDPI AG in Preprints.org
Drinking Water Systems as a Cocktail of Emerging Organic Contaminants: Occurrence, Public Health Risks, and Research Needs
Emerging organic contaminants (EOCs) of anthropogenic origins are ubiquitous in environmental compartments, including aquatic systems. Thus, EOCs have attracted considerable research and public attention due to their potential human and ecological health risks. However, compared to other aquatic environments such as wastewater systems, comprehensive reviews focussing on the occurrence and human health risks of EOCs in drinking water systems are still lacking. Therefore, to address this knowledge gap, the current review posits that drinking water systems harbour a cocktail of toxic EOCs, which pose public health risks via multiple exposure routes. In the present review, global evidence is examined to track EOCs along the source-pathway-receptor-impact-mitigation (SPRIM) continuum. Evidence shows that, various groups of EOCs, including pharmaceuticals and personal care products, solvents, plasticizers, endocrine disrupting compounds, gasoline additives, per- and polyfluoroalkyl substances (PFAS), food colourants, artificial sweeteners, and musks and fragrances, have been detected in drinking water systems. The anthropogenic sources of EOCs detected in drinking water systems, including wastewater systems and industrial emissions, are summarized. Further, the behaviour and fate of EOCs in the drinking water systems, including removal processes are discussed. Once in drinking water systems, human exposure to EOCs may occur via ingestion of contaminated drinking water and cooked foods, and possibly dermal contact and inhalation. The high-risk environments, and risk factors and behaviours predisposing humans to EOC exposure are discussed. Evidence on the human health risks of the various EOCs and a critique of the data are presented. Notably, besides inferential data, quantitative epidemiological evidence directly relating the occurrence of EOCs in drinking water systems to specific adverse human health outcomes is still scarce. Lastly, future research directions, including the need for quantitative public health risk assessment, and the application of emerging detection tools are discussed.
- 16 June 2023
- Published by MDPI AG in Preprints.org
Open AccessDrinking Water Systems as a Cocktail of Emerging Organic Contaminants: Occurrence, Public Health Risks, and Research Needs
Emerging organic contaminants (EOCs) of anthropogenic origins are ubiquitous in environmental compartments, including aquatic systems. Thus, EOCs have attracted considerable research and public attention due to their potential human and ecological health risks. However, compared to other aquatic environments such as wastewater systems, comprehensive reviews focussing on the occurrence and human health risks of EOCs in drinking water systems are still lacking. Therefore, to address this knowledge gap, the current review posits that drinking water systems harbour a cocktail of toxic EOCs, which pose public health risks via multiple exposure routes. In the present review, global evidence is examined to track EOCs along the source-pathway-receptor-impact-mitigation (SPRIM) continuum. Evidence shows that, various groups of EOCs, including pharmaceuticals and personal care products, solvents, plasticizers, endocrine disrupting compounds, gasoline additives, per- and polyfluoroalkyl substances (PFAS), food colourants, artificial sweeteners, and musks and fragrances, have been detected in drinking water systems. The anthropogenic sources of EOCs detected in drinking water systems, including wastewater systems and industrial emissions, are summarized. Further, the behaviour and fate of EOCs in the drinking water systems, including removal processes are discussed. Once in drinking water systems, human exposure to EOCs may occur via ingestion of contaminated drinking water and cooked foods, and possibly dermal contact and inhalation. The high-risk environments, and risk factors and behaviours predisposing humans to EOC exposure are discussed. Evidence on the human health risks of the various EOCs and a critique of the data are presented. Notably, besides inferential data, quantitative epidemiological evidence directly relating the occurrence of EOCs in drinking water systems to specific adverse human health outcomes is still scarce. Lastly, future research directions, including the need for quantitative public health risk assessment, and the application of emerging detection tools are discussed.
- 26 February 2023
- Published by Springer Nature
- p. 59-87
An Outstanding Perspective on Biological Dynamics in Vermicomposting Matrices
- 26 February 2023
- Published by Springer Nature
- p. 59-87
An Outstanding Perspective on Biological Dynamics in Vermicomposting Matrices
- 13 January 2023
- Published by Springer Nature
- p. 147-167
Indigenous Health Practices and Lifestyles: Can They Help Zimbabwe Transform Its Health Systems in the Face of the COVID-19 Pandemic?
- 13 January 2023
- Published by Springer Nature
- p. 147-167
Indigenous Health Practices and Lifestyles: Can They Help Zimbabwe Transform Its Health Systems in the Face of the COVID-19 Pandemic?
- 1 January 2023
- Published by Springer Nature
- p. 59-75
Contributions of Small Grains Grown in Zimbabwe’s Dryland Regions in Boosting Immunity and Combating COVID-19
- 1 January 2023
- Published by Springer Nature
- p. 59-75
Contributions of Small Grains Grown in Zimbabwe’s Dryland Regions in Boosting Immunity and Combating COVID-19
- Open Access
- 19 June 2020
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 14 (2) , 1157-1165
Antimicrobial-resistant Shiga-toxin producing Escherichia coli Isolated from Ready-to-Eat Meat Products and Fermented Milk Sold in the Formal and Informal Sectors in Harare, Zimbabwe
- 19 June 2020
- Published by Journal of Pure and Applied Microbiology in Journal of Pure and Applied Microbiology
- Vol. 14 (2) , 1157-1165
Open AccessAntimicrobial-resistant Shiga-toxin producing Escherichia coli Isolated from Ready-to-Eat Meat Products and Fermented Milk Sold in the Formal and Informal Sectors in Harare, Zimbabwe